Stock-based Compensation (Tables)

9 Months Ended

Dec. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

On May 18, 2018, the Company granted RSUs under the 2019/2020 LTIP with a grant date fair value of $17.86 that vest as follows (amounts in thousands):



	Shares
May 18, 2019	56
May 18, 2020	120
May 18, 2021	122
Total shares granted ^{(1) (2)}	298

__________________

⁽¹⁾ RSUs granted include a performance component. Therefore the granted shares shown above are an estimate based upon current performance expectations. The final number of shares granted depends on the achievement of performance metrics.

⁽²⁾ 36,059 in non-vested RSUs under the 2019/2020 LTIP were forfeited by the Company's prior Chief Executive Officer upon his resignation.

The following is the vesting schedule of RSUs under each respective LTIP, which vested during the nine months ended December 31, 2018 (shares in thousands):



	2018/2019	2017/2018	2016/2017
Time-based award vested	63	198	191
Performance-based award vested	—	—	173

Restricted stock activity, excluding the LTIP activity discussed above, for the nine months ended December 31, 2018 is as follows (amounts in thousands except fair value):



	Shares		Weighted- average Fair Value on Grant Date
Non-vested restricted stock at March 31, 2018	1,405		$	9.82
Granted	292		21.81
Vested	(1,066	)	9.49
Forfeited	(21	)	7.78
Non-vested restricted stock at December 31, 2018	610		$	16.21

Schedule of the compensation expense (recovery) associated with stock-based compensation

The compensation expense associated with stock-based compensation for the three months ended December 31, 2018 and 2017 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands):



	Three Months Ended December 31, 2018						Three Months Ended December 31, 2017
	Stock Options		Restricted Stock		LTIPs		Stock Options		Restricted Stock		LTIPs
Cost of sales	$	—	$	321	$	345	$	—	$	210	$	192
Selling, general and administrative expenses	—		547		220		—		1,262		490
Research and development	—		22		79		—		12		40
Total	$	—	$	890	$	644	$	—	$	1,484	$	722

The compensation expense associated with stock-based compensation for the nine months ended December 31, 2018 and 2017 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands):



	Nine Months Ended December 31, 2018						Nine Months Ended December 31, 2017
	Stock Options		Restricted Stock		LTIPs		Stock Options		Restricted Stock		LTIPs
Cost of sales	$	—	$	1,022	$	919	$	—	$	549	$	505
Selling, general and administrative expenses	—		6,236		1,580		—		2,345		1,294
Research and development	—		54		200		—		31		113
Total	$	—	$	7,312	$	2,699	$	—	$	2,925	$	1,912